Victoria Levasseur, M.D.

Specializing in:

Multiple Sclerosis • Neuro-Inflammatory Disease

Dr. Victoria Levasseur is a board certified neurologist with specialized fellowship training in multiple sclerosis and neuro-inflammatory disease. She obtained her medical degree at University of Missouri – Columbia, and completed neurology residency and fellowship at Washington University in St. Louis. She entered the field of neurology through the lens of scientific research, which provided her with a structured approach to unanswered questions in the field of neuroimmunology.

Her decision to join MCN was based on her drive to provide top-notch, quality care and the opportunity to work in a highly collaborative team-based environment – both of which are imperative to the success of a practice.

Outside of the clinic, Dr. Levasseur enjoys spending time with her family and friends, playing the cello, and learning about art. As a long distance runner, she believes that prioritizing self-care and staying on an exercise schedule can support overall health and help reduce stress.

The neurologist was amazing! Very compassionate and helped me so much!
PA was excellent as well!

Dr. Aggarwal gave me back my life, PA-C Donald Altenburg has helped me to keep it. Also, your office personnel are consistently welcoming and helpful.

Nice doctor, easy to talk to.

Bachelors of Arts – Cornell College, Mount Vernon, IA, 2011
NIH Postbaccalaureate Intramural Research Training – Bethesda, MD 2012
Doctor of Medicine – University of Missouri, Columbia, MO 2016
Neurology Residency – Washington University, St. Louis, MO, 2020
Fellowship in Multiple Sclerosis and Neuro-Immunology – Washington University, St. Louis, MO, 2022

Certification

Board Certified – American Board of Psychiatry and Neurology

Memberships

American Academy of Neurology

Publications

Harrison M, Gaudioso C, Levasseur VA et al (2023). Central Vein Sign in Pediatric Multiple Sclerosis and MOG Antibody Associated Disease. Pediatric Neurology. In Press

Ghezzi L, Levasseur VA, et al (2023). Extensive rebound MS activity following dimethyl fumarate discontinuation in a 63 year old – A case report. Neuroimmunology Reports. 3: 100175.

Levasseur VA, Xiang B, Salter A, Yablonskiy D, Cross A (2022). Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions with Central Vein Sign by Quantitative Gradient Echo MRI. Journal of CNS Disease. 14: 1-10.

Evans E, Levasseur VA, Cross A, Piccio L (2019). An Overview of the Current State of Evidence for the Role of Diets in Multiple Sclerosis. Multiple Scler Relat Disord. 36: 101393.

Adusumilli G, Lancia S, Levasseur VA, Amblee V, Orchard M, Wagner JM, Naismith RT (2018). Turning is an Important Marker of Balance Confidence and Walking Limitation in Persons with Multiple Sclerosis. PLoS One. 13 (6): e0198178

Johnson TV, DeKorver NW, Levasseur VA, Osborne A, Tassoni, A, Lorber B, Heller JP, Villasmil R, Bull ND, Martin KR, Tomarev SI (2014). Identification of Retinal Ganglion Cell Neuroprotection Conferred by Platelet-Derived Growth Factor Through Analysis of the Mesenchymal Stem Cell Secretome, Brain, 132(2): 503-519.

Grinberg YY, Dibbern ME, Levasseur VA, Kraig RP (2013). Insulin-Like Growth Factor-1 Abrogates Microglial Oxidative Stress and TNF-Alpha Responses to Spreading Depression, Journal of Neurochemistry, 126(5): 662-672.